*Restrictions and quantity limits apply. Click to view complete program terms and conditions. Medicare, Medicaid, and other federal and state healthcare program patients are not eligible.
Gastroparesis (GP) is common before, during, and sometimes in between migraine attacks.
GP can slow and even block the absorption of oral medication (pills), causing delayed, incomplete, or no migraine symptom relief.
Find out more about how the relationship between medication formulation (oral versus non-oral) may impact migraine symptom relief.
Bring this printable guide to your next appointment. This guide can be a valuable resource to your healthcare team so they fully understand the impact of migraine, associated gastroparesis (GP) and whether a non-oral medication may be right for your migraine treatment plan.
An independent resource from Migraine Meanderings
Migraine Meanderings is a patient-run organization dedicated to supporting individuals living with migraine. It offers educational resources, advocacy, and a community for those affected by migraine, aiming to bring awareness and encourage patient engagement. The organization provides various resources to help individuals understand migraine better and manage their condition effectively.
Migraine Disability Assessment (MIDAS) is designed to measure the disease-impact of migraine on migraine-sufferers. It is a questionnaire you share with your doctor to better understand how often and how severe your migraine attacks are and is designed to estimate how much migraine gets in the way of your daily life.
An independent resource from Migraine Buddy
Migraine Buddy is the #1 headache and migraine tracking app. It is engineered to enhance the quality of life for those living with migraines by facilitating meticulous tracking, reporting, and self-management of symptoms, which in turn can accelerate diagnosis and fine-tune treatment options.
Zembrace SymTouch and Tosymra are prescription medicines used to treat acute migraine headaches with or without aura in adults 18 years of age and older who have been diagnosed with migraine.
Offers the lowest, effective dose (3mg) in an easy-to-use sumatriptan autoinjector, providing significantly more patients pain freedom vs. placebo in as little as 30 minutes1:
*Restrictions and quantity limits apply. Click to view complete program terms and conditions. Medicare, Medicaid, and other federal and state healthcare program patients are not eligible.
Please see Important Safety Information.
Tosymra’s unique formulation, including the permeation enhancer Intravail®, allows rapid and efficient absorption of sumatriptan, delivering migraine pain relief in as little as 10 minutes with just one spray4-6:
*Restrictions and quantity limits apply. Click to view complete program terms and conditions. Medicare, Medicaid, and other federal and state healthcare program patients are not eligible.
Please see Important Safety Information.
An independent resource from ProCare PharmacyCare
ProCare PharmacyCare provides you with the ability to request a medication prescription from your established migraine doctor.
Just create an account, answer a few questions and they will send an e-prescription request to your doctor on your behalf. You can expect a response within 48 hours.
An independent resource from UpScript Health
If you do not have an established migraine doctor or would rather use telemedicine, UpScript Health provides you with real-time access to 100’s of independent expert clinicians.
Simply fill out an online questionnaire and complete a visit to discuss which migraine medication might be right for you.
An independent resource from BlinkRx
Blink Health (BlinkRx) utilizes digital cutting-edge technology to provide prescribed medications to patients with convenient home delivery. Eligible patients can get their prescription filled for as little as $0 through BlinkRx.*
*Restrictions and quantity limits apply. Click to view complete program terms and conditions. Medicare, Medicaid, and other federal and state healthcare program patients are not eligible.
Gastroparesis (GP) is common before, during, and sometimes in between migraine attacks.
GP can slow and even block the absorption of oral medication (pills), causing delayed, incomplete, or no migraine symptom relief.
Find out more about how the relationship between medication formulation (oral versus non-oral) may impact migraine symptom relief.
Bring this printable guide to your next appointment. This guide can be a valuable resource to your healthcare team so they fully understand the impact of migraine, associated gastroparesis (GP) and whether a non-oral medication may be right for your migraine treatment plan.
An independent resource from Migraine Meanderings
Migraine Meanderings is a patient-run organization dedicated to supporting individuals living with migraine. It offers educational resources, advocacy, and a community for those affected by migraine, aiming to bring awareness and encourage patient engagement. The organization provides various resources to help individuals understand migraine better and manage their condition effectively.
Migraine Disability Assessment (MIDAS) is designed to measure the disease-impact of migraine on migraine-sufferers. It is a questionnaire you share with your doctor to better understand how often and how severe your migraine attacks are and is designed to estimate how much migraine gets in the way of your daily life.
An independent resource from Migraine Buddy
Migraine Buddy is the #1 headache and migraine tracking app. It is engineered to enhance the quality of life for those living with migraines by facilitating meticulous tracking, reporting, and self-management of symptoms, which in turn can accelerate diagnosis and fine-tune treatment options.
Zembrace SymTouch and Tosymra are prescription medicines used to treat acute migraine headaches with or without aura in adults 18 years of age and older who have been diagnosed with migraine.
Offers the lowest, effective dose (3mg) in an easy-to-use sumatriptan autoinjector, providing significantly more patients pain freedom vs. placebo in as little as 30 minutes1:
*Restrictions and quantity limits apply. Click to view complete program terms and conditions. Medicare, Medicaid, and other federal and state healthcare program patients are not eligible.
Please see Important Safety Information.
Tosymra’s unique formulation, including the permeation enhancer Intravail®, allows rapid and efficient absorption of sumatriptan, delivering migraine pain relief in as little as 10 minutes with just one spray4-6:
*Restrictions and quantity limits apply. Click to view complete program terms and conditions. Medicare, Medicaid, and other federal and state healthcare program patients are not eligible.
Please see Important Safety Information.
An independent resource from ProCare PharmacyCare
ProCare PharmacyCare provides you with the ability to request a medication prescription from your established migraine doctor.
Just create an account, answer a few questions and they will send an e-prescription request to your doctor on your behalf. You can expect a response within 48 hours.
An independent resource from UpScript Health
If you do not have an established migraine doctor or would rather use telemedicine, UpScript Health provides you with real-time access to 100’s of independent expert clinicians.
Simply fill out an online questionnaire and complete a visit to discuss which migraine medication might be right for you.
An independent resource from BlinkRx
Blink Health (BlinkRx) utilizes digital cutting-edge technology to provide prescribed medications to patients with convenient home delivery. Eligible patients can get their prescription filled for as little as $0 through BlinkRx.*
*Restrictions and quantity limits apply. Click to view complete program terms and conditions. Medicare, Medicaid, and other federal and state healthcare program patients are not eligible.
Do not take Zembrace® SymTouch® or Tosymra® if you have hemiplegic migraines or basilar migraines or to treat cluster headache.
IMPORTANT SAFETY INFORMATION
Zembrace SymTouch or Tosymra can cause serious side effects, including heart attack and other heart problems, which may lead to death. Stop Zembrace Symtouch or Tosymra and get emergency medical help if you have any signs of heart attack:
Zembrace and Tosymra are not for people with risk factors for heart disease (high blood pressure or cholesterol, smoking, overweight, diabetes, family history of heart disease) unless a heart exam shows no problem.
Do not use Zembrace or Tosymra if you have:
Tell your provider about all of your medical conditions and medicines you take, including vitamins and supplements.
Zembrace and Tosymra can cause dizziness, weakness, or drowsiness. If so, do not drive a car, use machinery, or do anything where you need to be alert.
Zembrace and Tosymra may cause serious side effects including:
The most common side effects of Zembrace and Tosymra include: pain and redness at injection site (Zembrance only); tingling or numbness in your fingers or toes; dizziness; warm, hot, burning feeling to your face (flushing); discomfort or stiffness in your neck; feeling weak, drowsy, or tired; application site (nasal) reactions (Tosymra only) and throat irritation (Tosymra only).
Tell your provider if you have any side effect that bothers you or does not go away. These are not all the possible side effects of Zembrace and Tosymra. For more information, ask your provider.
This is the most important information to know about Zembrace and Tosymra but is not comprehensive. For more information, talk to your provider and read the Patient Information and Instructions for Use. You can also visit https://www.tonixpharma.com or call 1-888-869-7633.
You are encouraged to report adverse effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.